Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Toxicon ; 86: 89-95, 2014 Aug.
Article in English | MEDLINE | ID: mdl-24878372

ABSTRACT

Basic phospholipases A2 (PLA2) are toxic and induce a wide spectrum of pharmacological effects, although the acidic enzyme types are not lethal or cause low lethality. Therefore, it is challenging to elucidate the mechanism of action of acidic phospholipases. This study used the acidic non-toxic Ba SpII RP4 PLA2 from Bothrops alternatus as an antigen to develop anti-PLA2 IgG antibodies in rabbits and used in vivo assays to examine the changes in crude venom when pre-incubated with these antibodies. Using Ouchterlony and western blot analyses on B. alternatus venom, we examined the specificity and sensitivity of phospholipase A2 recognition by the specific antibodies (anti-PLA2 IgG). Neutralisation assays using a non-toxic PLA2 antigen revealed unexpected results. The (indirect) haemolytic activity of whole venom was completely inhibited, and all catalytically active phospholipases A2 were blocked. Myotoxicity and lethality were reduced when the crude venom was pre-incubated with anti-PLA2 immunoglobulins. CK levels in the skeletal muscle were significantly reduced at 6 h, and the muscular damage was more significant at this time-point compared to 3 and 12 h. When four times the LD50 was used (224 µg), half the animals treated with the venom-anti PLA2 IgG mixture survived after 48 h. All assays performed with the specific antibodies revealed that Ba SpII RP4 PLA2 had a synergistic effect on whole-venom toxicity. IgG antibodies against the venom of the Argentinean species B. alternatus represent a valuable tool for elucidation of the roles of acidic PLA2 that appear to have purely digestive roles and for further studies on immunotherapy and snake envenoming in affected areas in Argentina and Brazil.


Subject(s)
Antibodies, Anti-Idiotypic/biosynthesis , Antivenins/chemistry , Crotalid Venoms/antagonists & inhibitors , Immunoglobulin G/biosynthesis , Phospholipase A2 Inhibitors/chemistry , Phospholipases A2/chemistry , Animals , Antibodies, Neutralizing/biosynthesis , Antibodies, Neutralizing/isolation & purification , Antibody Specificity , Bothrops , Crotalid Venoms/immunology , Immunoglobulin G/isolation & purification , Male , Mice , Neutralization Tests , Rabbits
2.
Toxicon ; 59(2): 338-43, 2012 Feb.
Article in English | MEDLINE | ID: mdl-22133569

ABSTRACT

Acute muscle damage, myonecrosis, is one of the main characteristics of envenoming by Bothrops genus. In this in vitro study we investigated the role of a metalloproteinase (baltergin) and an acidic phospholipase A2 (Ba SPII RP4) in the cytotoxicity exhibited by Bothrops alternatus venom. Baltergin metalloproteinase purified from the venom exerted a toxic effect on C2C12 myoblast cells (CC50: 583.34 µg/mL) which involved morphological alterations compatible with apoptosis/anoikis. On the contrary, the most abundant PLA2 isolated from this venom did not exhibit cytotoxicity at times and doses tested. However, when myoblasts were treated with both enzymes together, synergic activity was demonstrated. Neutralization of the venom with specific antibodies (IgG anti-baltergin and IgG anti-PLA2) confirmed this synergism.


Subject(s)
Bothrops/metabolism , Crotalid Venoms/enzymology , Crotalid Venoms/pharmacology , Metalloproteases/pharmacology , Phospholipases A2/pharmacology , Animals , Antibodies, Monoclonal/blood , Cell Line , Drug Synergism , Mice , Mice, Inbred C3H , Muscle, Skeletal/drug effects , Muscular Diseases/chemically induced , Muscular Diseases/pathology , Rabbits
3.
Toxicon ; 56(1): 64-74, 2010 Aug 01.
Article in English | MEDLINE | ID: mdl-20331996

ABSTRACT

An acidic protein with phospholipase A(2) activity was purified to homogeneity from the venom of the Northeast Argentinian viperid Bothrops alternatus by two chromatographic steps: a conventional gel filtration on Sephadex G-75 and reversed phase on C18 HPLC column. A molecular mass of 14185.48 Da was determined by mass spectrometry, displaying a homodimer conformation. The kinetic assay demonstrated a catalytically active phospholipase A(2) in correspondence with Asp49 PLA(2) group. The enzyme designated Ba SpII RP4 contains an amino acid composition of 121 residues and a calculated theoretical pI value of 4.88. Amino acid sequence alignments with other Bothrops PLA(2) revealed a high degree of homology sequence (90-56%). Ba SpII RP4 did not show myotoxic activity upon muscular fibers at doses up to 100 microg i.m. route injection or lethal response when it was i.p. injected at the hightest dose of 200 microg. This toxin generates slight biological activities like paw edema inflammation and a delay in the clotting time, although Ba SpII RP4 exhibited catalytic activity. The primary amino acid sequence, determined a quadruple-time of flight (Q-TOF) hybrid mass spectrometer Q-TOF Ultima from Micromass (Manchester, UK) equipped with a nano Zspray source operating in a positive ion mode and tandem mass spectrum, an ESI/MS mass spectrum (TOF MS mode) "de novo amino acid sequencing", also provides more database about the small group of the non-myotoxic PLA(2)s isolated up to the present.


Subject(s)
Anticoagulants , Bothrops , Crotalid Venoms/enzymology , Group III Phospholipases A2 , Hemolytic Agents , Reptilian Proteins , Alkylation , Amino Acid Sequence , Animals , Anticoagulants/chemistry , Anticoagulants/isolation & purification , Anticoagulants/metabolism , Anticoagulants/toxicity , Argentina , Creatine Kinase/blood , Edema/chemically induced , Group III Phospholipases A2/chemistry , Group III Phospholipases A2/isolation & purification , Group III Phospholipases A2/metabolism , Group III Phospholipases A2/toxicity , Hemolytic Agents/chemistry , Hemolytic Agents/isolation & purification , Hemolytic Agents/metabolism , Hemolytic Agents/toxicity , Hydrogen-Ion Concentration , Kinetics , Lethal Dose 50 , Mice , Molecular Sequence Data , Molecular Weight , Muscles/drug effects , Muscles/pathology , Oxidation-Reduction , Peptide Fragments/chemistry , Peptide Fragments/isolation & purification , Protein Multimerization , Reptilian Proteins/chemistry , Reptilian Proteins/isolation & purification , Reptilian Proteins/metabolism , Reptilian Proteins/toxicity , Sequence Alignment , Sequence Homology, Amino Acid
SELECTION OF CITATIONS
SEARCH DETAIL
...